Cybin teams with research firm Worldwide Clinical Trials to develop CYB003

Cybin announced that it has partnered with Worldwide Clinical Trials , a global, full-service contract research organization with deep expertise managing clinical trials for mental health conditions, including major depressive disorder. To date, the partnership with Worldwide has been pivotal in the development of study designs, defining global regulatory strategy and navigation of regulatory pathways, and pharmacovigilance. Worldwide has a track record of successful patient recruitment for psychedelic trials and global relationships with best-in-class investigative sites…”At Worldwide, we share a passion for Cybin’s mission to revolutionize mental healthcare,” said Dr. Michael Murphy, Chief Medical and Scientific Officer of Worldwide Clinical Trials. “We are proud to partner with such a diverse and extraordinary group of experts to help create safe and effective psychedelic-based therapies to transform potential treatment options for patients who live with mental health disorders.”